Attached files
| file | filename |
|---|---|
| EX-99.1 - EX-99.1 - Astria Therapeutics, Inc. | a18-10090_1ex99d1.htm |
| 8-K - 8-K - Astria Therapeutics, Inc. | a18-10090_18k.htm |
Product Candidate (Pathway) Discovery Preclin Phase 1 Phase 2 Phase 3 Edasalonexent CAT-1004 (NF-kB) Edasalonexent CAT-1004 (NF-kB) Edasalonexent CAT-1004 (NF-kB) CAT-5571 (Autophagy) Duchenne muscular dystrophy (4-7 yo) Phase 2 complete Preparing for Phase 3 IND-enabled Non-Ambulatory DMD Cystic fibrosis Becker Muscular Dystrophy Designing Phase 2 Exploring potential in BMD
